These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19882635)

  • 1. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
    Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
    Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
    Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different characteristic phenotypes according to antibody in myasthenia gravis.
    Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
    Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
    Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
    J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with patients with anti-MUSK antibody positive myasthenia gravis.
    Sundar U; Shaunbhag P; Lakkas Y; Shrivastava M; Shah A; Vaidya M; Asole D
    J Assoc Physicians India; 2010 Oct; 58():640-2. PubMed ID: 21510119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the management of refractory myasthenia gravis.
    Zebardast N; Patwa HS; Novella SP; Goldstein JM
    Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.